Wieding JU et al., 1992-04: German 1992 clinical and in-vitro study of methylene-blue-treated fresh frozen plasma: 519 units given to 103 patients with no specific clinical reactions, but clots appeared in 9 of the first 110 units and in-vitro work showed methylene blue plus light generates fibrin(ogen) derivatives.
However, after thawing, clots were observed in 9 of the first 110 units
84-90
Wieding JU et al., 1992-04: German 1992 clinical and in-vitro study of methylene-blue-treated fresh frozen plasma: 519 units given to 103 patients with no specific clinical reactions, but clots appeared in 9 of the first 110 units and in-vitro work showed methylene blue plus light generates fibrin(ogen) derivatives. C5 Germany (Infusionsther Transfusionsmed 19(2):84-90). Study type: clinical observational study (519 FFP units, 103 patients) plus in-vitro experiments. Methylene blue photodynamic treatment of single-donor plasma; concentration not in the abstract. Comparator: conventional FFP (clots 'extremely rare'). Funder/conflicts not stated. Bearing PARTLY: the virucidal use is documented but the paper reports a product-quality harm signal. Study type: uncontrolled series.
